Medirom Healthcare Technologies income statement data for the quarter ended Jun 2025. This income statement covers 12 quarters of results from Dec 2019 through Jun 2025, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2019 | Dec2020 | Jun2021 | Aug2021 | Dec2021 | Jun2022 | Dec2022 | Jun2023 | Dec2023 | Jun2024 | Dec2024 | Jun2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||
| Revenue | 8.23M | 12.86M | 5.12M | |||||||||
| Non-operating items | ||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 29.27M | 26.71M | 43.35M | |||||||||
| Net income details | ||||||||||||
| Profit After TaxPAT | 0.64M | 5.39M | 0.76M | |||||||||
| Additional items | ||||||||||||
| Shares Outstanding | 3.75M | 4.02M | 4.02M | 4.02M | 4.88M | 4.88M | 4.88M | 4.88M | 4.88M | 4.88M | 5.11M | 5.11M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 4.27M | 4.02M | 4.02M | 4.02M | 4.88M | 4.88M | 5.47M | 5.47M | 5.17M | 5.17M | 5.85M | 5.85M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 4.12M | 4.82M | 4.88M | 4.88M | 4.88M | 5.11M |